This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Coeptis Therapeutics Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Dave Mehalick

Algemeen directeur

US$216.5k

Totale compensatie

Percentage CEO-salaris	100.0%
Dienstverband CEO	1.6yrs
Eigendom CEO	3.5%
Management gemiddelde ambtstermijn	geen gegevens
Gemiddelde ambtstermijn bestuur	1.2yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Dave Mehalick's beloning veranderd ten opzichte van Coeptis Therapeutics's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Jun 30 2022	n/a	n/a	-US$38m
Mar 31 2022	n/a	n/a	-US$31m
Dec 31 2021	US$217k	US$217k	-US$13m
Sep 30 2021	n/a	n/a	-US$15m
Jun 30 2021	n/a	n/a	-US$11m
Mar 31 2021	n/a	n/a	-US$9m
Dec 31 2020	US$149k	US$149k	-US$9m
Dec 31 2019	US$147k	US$147k	-US$2m

Compensatie versus markt: Dave's total compensation ($USD216.50K) is below average for companies of similar size in the US market ($USD1.64M).

Compensatie versus inkomsten: Dave's compensation has increased whilst the company is unprofitable.

CEO

Dave Mehalick (53 yo)

1.6yrs

Tenure

US$216,500

Compensatie

Mr. David Mehalick, also known as Dave, is Chief Business Officer at Sparta Healthcare Acquisition Corp. He is a co-founder of Coeptis Therapeutics Inc. (formerly known as Vinings Holdings Inc.) (formerly...

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
David Mehalick	Co-Founder	1.6yrs	US$216.50k	3.52% $ 6.0m
Christine Sheehy	Co-Founder	1.6yrs	US$133.50k	5.86% $ 10.1m
Daniel Yerace	Co-Founder	1.6yrs	US$205.50k	5.86% $ 10.1m
Evren Alici	Member of Scientific and Clinical Advisory Board	less than a year	geen gegevens	geen gegevens
Hans-Gustaf Ljunggren	Member of Scientific and Clinical Advisory Board	less than a year	geen gegevens	geen gegevens
Arnika Wagner	Member of Scientific and Clinical Advisory Board	less than a year	geen gegevens	geen gegevens

1.2yrs

Gemiddelde duur

53yo

Gemiddelde leeftijd

Ervaren bestuur: COEP's board of directors are not considered experienced ( 1.2 years average tenure), which suggests a new board.